The SPP biotech module 1: proteins for medical applications: a multidisciplinary effort for the development of a recombinant anti-RhD antibody preparation for the prevention of hemolytic disease of the newborn

Amstutz, H.Miescher, S.Moudry, R.Dejardin, S.Imboden, M.Morgenthaler, J. J.Zahn, M.Kobr, M.Fisch, I.Corthesy, B.Mermod, N.Berruex, L.Abdellali, M.Bruggemann, O.Fraboulet, D.Freitag, R.Kragten, E.Nahrgang, S.Ducommun, P.Pugeaud, P.Marison, I.Von Stockar, U.De Jesus, M.Jordan, M.Bourgeois, M.Hunt, L.Radice, S.Baldi, L.Kulangara, A.Girard, P.Ribicki, R.Wurm, F. M.2006-02-272006-02-272006-02-27199910.1007/0-306-46875-1_96https://infoscience.epfl.ch/handle/20.500.14299/226030A review with 0 refs. is presented regarding studies of a multidisciplinary team to establish the prophylactic principle and the manufg. process for anti-Rh D therapy based on recombinant antibody prepns. produced from Chinese hamster ovary cells. [on SciFinder (R)]The SPP biotech module 1: proteins for medical applications: a multidisciplinary effort for the development of a recombinant anti-RhD antibody preparation for the prevention of hemolytic disease of the newborntext::conference output::conference proceedings::conference paper